- call +1-201-465-4211
- email sales@mrinsights.biz
Scope of the Report:
This report focuses on the Parkinson's Disease in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Parkinson's Disease is expected to grow at a CAGR of roughly 5.9% over the next five years, will reach 5980 million US$ in 2023, from 4240 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Teva
Novartis
GSK
AbbVie
Merck
Boehringer Ingelheim
Impax
Lundbeck
Sun Pharma
Wockhardt
UCB
Valeant Pharmaceuticals
Acadia
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Carbidopa/Levodopa
Dopamine Receptor Agonists
MAO-Inhibitors
Market Segment by Applications, can be divided into
Hospitals
Clinics
There are 15 Chapters to deeply display the global Parkinson's Disease market.
Chapter 1, to describe Parkinson's Disease Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Parkinson's Disease, with sales, revenue, and price of Parkinson's Disease, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Parkinson's Disease, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Parkinson's Disease market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Parkinson's Disease sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Parkinson's Disease Introduction
1.2 Market Analysis by Type
1.2.1 Carbidopa/Levodopa
1.2.2 Dopamine Receptor Agonists
1.2.3 MAO-Inhibitors
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Clinics
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Teva
2.1.1 Business Overview
2.1.2 Parkinson's Disease Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Teva Parkinson's Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Novartis
2.2.1 Business Overview
2.2.2 Parkinson's Disease Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis Parkinson's Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 GSK
2.3.1 Business Overview
2.3.2 Parkinson's Disease Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 GSK Parkinson's Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 AbbVie
2.4.1 Business Overview
2.4.2 Parkinson's Disease Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 AbbVie Parkinson's Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Merck
2.5.1 Business Overview
2.5.2 Parkinson's Disease Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Merck Parkinson's Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Boehringer Ingelheim
2.6.1 Business Overview
2.6.2 Parkinson's Disease Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Boehringer Ingelheim Parkinson's Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Impax
2.7.1 Business Overview
2.7.2 Parkinson's Disease Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Impax Parkinson's Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Lundbeck
2.8.1 Business Overview
2.8.2 Parkinson's Disease Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Lundbeck Parkinson's Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Sun Pharma
2.9.1 Business Overview
2.9.2 Parkinson's Disease Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Sun Pharma Parkinson's Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Wockhardt
2.10.1 Business Overview
2.10.2 Parkinson's Disease Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Wockhardt Parkinson's Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 UCB
2.11.1 Business Overview
2.11.2 Parkinson's Disease Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 UCB Parkinson's Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Valeant Pharmaceuticals
2.12.1 Business Overview
2.12.2 Parkinson's Disease Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Valeant Pharmaceuticals Parkinson's Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Acadia
2.13.1 Business Overview
2.13.2 Parkinson's Disease Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Acadia Parkinson's Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Parkinson's Disease Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Parkinson's Disease Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Parkinson's Disease Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Parkinson's Disease Manufacturer Market Share in 2017
3.3.2 Top 6 Parkinson's Disease Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Parkinson's Disease Market Analysis by Regions
4.1 Global Parkinson's Disease Sales, Revenue and Market Share by Regions
4.1.1 Global Parkinson's Disease Sales and Market Share by Regions (2013-2018)
4.1.2 Global Parkinson's Disease Revenue and Market Share by Regions (2013-2018)
4.2 North America Parkinson's Disease Sales and Growth Rate (2013-2018)
4.3 Europe Parkinson's Disease Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Parkinson's Disease Sales and Growth Rate (2013-2018)
4.5 South America Parkinson's Disease Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Parkinson's Disease Sales and Growth Rate (2013-2018)
5 North America Parkinson's Disease by Countries
5.1 North America Parkinson's Disease Sales, Revenue and Market Share by Countries
5.1.1 North America Parkinson's Disease Sales and Market Share by Countries (2013-2018)
5.1.2 North America Parkinson's Disease Revenue and Market Share by Countries (2013-2018)
5.2 United States Parkinson's Disease Sales and Growth Rate (2013-2018)
5.3 Canada Parkinson's Disease Sales and Growth Rate (2013-2018)
5.4 Mexico Parkinson's Disease Sales and Growth Rate (2013-2018)
6 Europe Parkinson's Disease by Countries
6.1 Europe Parkinson's Disease Sales, Revenue and Market Share by Countries
6.1.1 Europe Parkinson's Disease Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Parkinson's Disease Revenue and Market Share by Countries (2013-2018)
6.2 Germany Parkinson's Disease Sales and Growth Rate (2013-2018)
6.3 UK Parkinson's Disease Sales and Growth Rate (2013-2018)
6.4 France Parkinson's Disease Sales and Growth Rate (2013-2018)
6.5 Russia Parkinson's Disease Sales and Growth Rate (2013-2018)
6.6 Italy Parkinson's Disease Sales and Growth Rate (2013-2018)
7 Asia-Pacific Parkinson's Disease by Countries
7.1 Asia-Pacific Parkinson's Disease Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Parkinson's Disease Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Parkinson's Disease Revenue and Market Share by Countries (2013-2018)
7.2 China Parkinson's Disease Sales and Growth Rate (2013-2018)
7.3 Japan Parkinson's Disease Sales and Growth Rate (2013-2018)
7.4 Korea Parkinson's Disease Sales and Growth Rate (2013-2018)
7.5 India Parkinson's Disease Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Parkinson's Disease Sales and Growth Rate (2013-2018)
8 South America Parkinson's Disease by Countries
8.1 South America Parkinson's Disease Sales, Revenue and Market Share by Countries
8.1.1 South America Parkinson's Disease Sales and Market Share by Countries (2013-2018)
8.1.2 South America Parkinson's Disease Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Parkinson's Disease Sales and Growth Rate (2013-2018)
8.3 Argentina Parkinson's Disease Sales and Growth Rate (2013-2018)
8.4 Colombia Parkinson's Disease Sales and Growth Rate (2013-2018)
9 Middle East and Africa Parkinson's Disease by Countries
9.1 Middle East and Africa Parkinson's Disease Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Parkinson's Disease Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Parkinson's Disease Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Parkinson's Disease Sales and Growth Rate (2013-2018)
9.3 UAE Parkinson's Disease Sales and Growth Rate (2013-2018)
9.4 Egypt Parkinson's Disease Sales and Growth Rate (2013-2018)
9.5 Nigeria Parkinson's Disease Sales and Growth Rate (2013-2018)
9.6 South Africa Parkinson's Disease Sales and Growth Rate (2013-2018)
10 Global Parkinson's Disease Market Segment by Type
10.1 Global Parkinson's Disease Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Parkinson's Disease Sales and Market Share by Type (2013-2018)
10.1.2 Global Parkinson's Disease Revenue and Market Share by Type (2013-2018)
10.2 Carbidopa/Levodopa Sales Growth and Price
10.2.1 Global Carbidopa/Levodopa Sales Growth (2013-2018)
10.2.2 Global Carbidopa/Levodopa Price (2013-2018)
10.3 Dopamine Receptor Agonists Sales Growth and Price
10.3.1 Global Dopamine Receptor Agonists Sales Growth (2013-2018)
10.3.2 Global Dopamine Receptor Agonists Price (2013-2018)
10.4 MAO-Inhibitors Sales Growth and Price
10.4.1 Global MAO-Inhibitors Sales Growth (2013-2018)
10.4.2 Global MAO-Inhibitors Price (2013-2018)
11 Global Parkinson's Disease Market Segment by Application
11.1 Global Parkinson's Disease Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Clinics Sales Growth (2013-2018)
12 Parkinson's Disease Market Forecast (2018-2023)
12.1 Global Parkinson's Disease Sales, Revenue and Growth Rate (2018-2023)
12.2 Parkinson's Disease Market Forecast by Regions (2018-2023)
12.2.1 North America Parkinson's Disease Market Forecast (2018-2023)
12.2.2 Europe Parkinson's Disease Market Forecast (2018-2023)
12.2.3 Asia-Pacific Parkinson's Disease Market Forecast (2018-2023)
12.2.4 South America Parkinson's Disease Market Forecast (2018-2023)
12.2.5 Middle East and Africa Parkinson's Disease Market Forecast (2018-2023)
12.3 Parkinson's Disease Market Forecast by Type (2018-2023)
12.3.1 Global Parkinson's Disease Sales Forecast by Type (2018-2023)
12.3.2 Global Parkinson's Disease Market Share Forecast by Type (2018-2023)
12.4 Parkinson's Disease Market Forecast by Application (2018-2023)
12.4.1 Global Parkinson's Disease Sales Forecast by Application (2018-2023)
12.4.2 Global Parkinson's Disease Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Parkinson's Disease Picture
Table Product Specifications of Parkinson's Disease
Figure Global Sales Market Share of Parkinson's Disease by Types in 2017
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
